IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Frazier Management LLC

Q4 2018 Holdings

Filed 2019-02-11 | 17 holdings | $32.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Collegium Pharmaceutical Inc(COLL)COM19459J104$32.4M1,887,33298.9%
Anaptysbio Inc(ANAB)COM032724106$147.8K2,316,4470.5%
Aptinyx IncCOM03836N103$52.8K3,190,0790.2%
Gritstone Oncology Inc(2JQ)COM39868T105$31.9K2,061,7580.1%
Iovance Biotherapeutics Inc(IOVA)COM462260100$19.4K2,188,3310.1%
Krystal Biotech Inc(KRYS)COM501147102$18.2K875,0000.1%
Allena Pharmaceuticals Inc(ALNAEUR)COM018119107$18.2K3,330,3730.1%
Millendo Therapeutics IncCOM60040X103$11.1K1,396,6150.0%
Sierra Oncology IncCOM82640U107$10.7K8,112,1210.0%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$8.1K2,199,0110.0%
Iterum Therapeutics PLCSHSG6333L101$7.7K1,538,3160.0%
Synlogic IncCOM87166L100$6.1K865,4070.0%
Kezar Life Sciences IncCOM49372L100$5.9K250,0000.0%
Nabriva Therapeutics PLCSHSG63637105$5.9K4,012,3740.0%
Entasis Therapeutics Hldgs ICOM293614103$5.5K1,349,9530.0%
Cidara Therapeutics IncCOM171757107$3.1K1,312,2580.0%
Bellicum Pharmaceuticals IncCOM079481107$3.1K1,051,4410.0%